137 related articles for article (PubMed ID: 3410234)
1. Effect of terbutaline, a beta 2-adrenoreceptor agonist, on gastric acid secretion and serum gastrin concentrations in humans.
Thirlby RC; Richardson CT; Chew P; Feldman M
Gastroenterology; 1988 Oct; 95(4):913-9. PubMed ID: 3410234
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of beta-adrenergic agonists on gastric acid secretion in dogs.
Stevens MH; Thirlby RC; Richardson CT; Fredrickson MA; Unger RH; Feldman M
Am J Physiol; 1986 Oct; 251(4 Pt 1):G453-9. PubMed ID: 2876645
[TBL] [Abstract][Full Text] [Related]
3. Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs.
Kogire M; Izukura M; Gomez G; Uchida T; Greeley GH; Thompson JC
Dig Dis Sci; 1990 Apr; 35(4):453-7. PubMed ID: 2156661
[TBL] [Abstract][Full Text] [Related]
4. The effect of a gastrin-receptor antagonist on gastric acid secretion and serum gastrin in the Zollinger-Ellison syndrome.
Lamers CB; Jansen JB
J Clin Gastroenterol; 1983 Feb; 5(1):21-4. PubMed ID: 6841943
[TBL] [Abstract][Full Text] [Related]
5. Effects of nifedipine on gastric acid secretion and gastrin release in man.
McColl KE; Buchanan NM; Laferla G; Hearns J; Buchanan K; Crean GP
Gut; 1987 Apr; 28(4):455-9. PubMed ID: 3556337
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral nalmefene, an opiate-receptor antagonist, on meal-stimulated gastric acid secretion and serum gastrin concentration in man.
Feldman M; Moore L; Walsh JH
Regul Pept; 1985 Jul; 11(3):245-50. PubMed ID: 4059587
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
8. Variable contribution of gastrin to gastric acid secretion after a meal in humans.
Blair AJ; Richardson CT; Walsh JH; Feldman M
Gastroenterology; 1987 Apr; 92(4):944-9. PubMed ID: 3557000
[TBL] [Abstract][Full Text] [Related]
9. Effect of propranolol on secretin-induced gastrin release and secretin-induced tachycardia in patients with the Zollinger-Ellison syndrome.
Goldschmeidt M; Redfern JS; Feldman M
Aliment Pharmacol Ther; 1990 Aug; 4(4):325-31. PubMed ID: 2103752
[TBL] [Abstract][Full Text] [Related]
10. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
Jansen JB; Lamers CB
Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
[TBL] [Abstract][Full Text] [Related]
11. Intravenous infusion of L-isomers of phenylalanine and tryptophan stimulate gastric acid secretion at physiologic plasma concentrations in normal subjects and after parietal cell vagotomy.
McArthur KE; Isenberg JI; Hogan DL; Dreier SJ
J Clin Invest; 1983 May; 71(5):1254-62. PubMed ID: 6853713
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
Ippoliti AF; Isenberg JI; Hagie L
Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
[TBL] [Abstract][Full Text] [Related]
13. Investigation of mechanism of fade of gastrin-stimulated gastric acid secretion in the cat.
Hirst BH
J Physiol; 1988 Jan; 395():319-31. PubMed ID: 3411480
[TBL] [Abstract][Full Text] [Related]
14. Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings.
Feldman M; Richardson CT; Walsh JH
J Clin Invest; 1983 Mar; 71(3):715-20. PubMed ID: 6826731
[TBL] [Abstract][Full Text] [Related]
15. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.
Colturi TJ; Unger RH; Feldman M
J Clin Invest; 1984 Aug; 74(2):417-23. PubMed ID: 6146638
[TBL] [Abstract][Full Text] [Related]
16. Effect of sham feeding on acid secretion in patients with Zollinger-Ellison syndrome with or without proximal gastric vagotomy.
Feldman M; Thirlby RC; Richardson CT
Scand J Gastroenterol; 1987 Apr; 22(3):321-4. PubMed ID: 3589501
[TBL] [Abstract][Full Text] [Related]
17. Effect of nifedipine on gastric acid secretion and gastrin release in healthy man.
Caldara R; Masci E; Barbieri C; Sorghi M; Piepoli V; Tittobello A
Eur J Clin Pharmacol; 1985; 28(6):677-9. PubMed ID: 4065191
[TBL] [Abstract][Full Text] [Related]
18. Prolonged inhibition of meal-stimulated acid secretion and gastrin release following single subcutaneous administration of octreotide (SMS 201-995) in man.
Karnes WE; Maxwell V; Sytnik B; Chew P; Walsh JH
Aliment Pharmacol Ther; 1989 Dec; 3(6):527-38. PubMed ID: 2518866
[TBL] [Abstract][Full Text] [Related]
19. Therapy with gastrin antibody in the Zollinger-Ellison syndrome.
Hughes WS; Hughes JB; Ritzmann SE
Am J Dig Dis; 1976 Mar; 21(3):201-4. PubMed ID: 1266836
[TBL] [Abstract][Full Text] [Related]
20. Impact of stress on serum gastrin in Zollinger-Ellison syndrome.
Nomura T; Fukudo S; Muranaka M; Iwahashi S; Sasaki M; Satake M; Sasaki I; Shibata C; Matsuno S
Am J Gastroenterol; 1993 Sep; 88(9):1432-5. PubMed ID: 8362843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
